Location: United States (East Coast preferred)
Reporting to: CEO
Commitment: Full-time
Compensation: $150,000-$175,000, High-performance bonus opportunity of up to 100% of base salary
GLP-1 therapies are rapidly transforming the treatment of obesity and metabolic disease. As adoption scales across telehealth platforms, obesity medicine clinics and digital health programs, a new challenge is emerging:
What happens after treatment ends?
The transition phase following GLP-1 discontinuation is increasingly recognised as a critical stage in long-term weight management. Patients often experience weight rebound, driven by fat mass regain, increased appetite signalling, and deterioration in metabolic markers. Despite the scale of GLP-1 adoption, this phase remains largely unaddressed.
This gap is creating a new category opportunity centred on post-GLP-1 metabolic transition support and weight-loss durability.
About the Business Development Director opportunity
To design and execute the US post-GLP-1 commercial strategy, translate clinical evidence into a differentiated market position, and build sustainable revenue through strategic partnerships.This is a “builder role” effectively a business within a business.You will own the strategy from inception to execution. You will be operating without a pre-existing team or playbook and be expected to build momentum independently in a new market category. You will be able to collaborate with the wider organizations internal marketing, R&D, regulatory and leadership teams.
Key Responsibilities:
Define and execute the US go-to-market strategy, identify and prioritise GLP-1 pathway partners, build a structured target account plan and negotiate / secure commercial partnerships outside of existing and traditional customer base
Develop a new commercial model beyond traditional supplement channels by engaging telehealth platforms, obesity clinics, digital health companies, and practitioner networks
Build relationships with decision makers and Key Opinion Leaders (KOLs)
Deliver revenue from differentiated applications, drive adoption within post-GLP-1 care pathways, whilst maintaining clear separation from legacy ingredient supply
Work closely with internal scientific, regulatory, and R&D teams, translate clinical data into compelling commercial narratives and support market education around post-GLP-1 outcomes
Build awareness in emerging channels, support marketing and commercial initiatives and help define category language and positioning
Candidate Profile
Background:
Experience in nutraceuticals, ingredients, or adjacent health sectors
Preference for familiarity partnering with telehealth platforms, obesity clinics, digital health companies, and practitioner networks
Track record of building new markets or business lines
Experience in entrepreneurial or high-growth environments
Skills & Experience:
Strong commercial execution capability
Ability to operate in unstructured, early-stage environments
Scientific literacy and ability to communicate clinical data
Experience engaging senior stakeholders and decision makers
Self-starter with strong ownership mindset
Resilient and comfortable with ambiguity
Clear, credible, and engaging communicator
Commercially driven without being overly “sales-led”